Entera Stock Based Compensation from 2010 to 2024

ENTX Stock

USD 1.64 0.06 3.53%

Entera Bio Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2016-09-30

Previous Quarter

598 K

Current Value

928 K

Quarterly Volatility

409.3 K

Covid

Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.76. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.

Check out the analysis of Entera Bio Correlation against competitors.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Latest Entera Bio's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Entera Bio over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Entera Bio's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Entera Stock Based Compensation Regression Statistics

	Arithmetic Mean	1,330,633
	Geometric Mean	941,052
	Coefficient Of Variation	90.10
	Mean Deviation	842,009
	Median	1,233,000
	Standard Deviation	1,198,909
	Sample Variance	1.4T
	Range	4.5M
	R-Value	0.51
	Mean Square Error	1.1T
	R-Squared	0.26
	Significance	0.05
	Slope	136,302
	Total Sum of Squares	20.1T

Entera Stock Based Compensation History

	2024	2 M
	2023	1.7 M
	2022	2.2 M
	2021	1.9 M
	2020	901 K
	2019	1.5 M
	2018	1.2 M

Other Fundumenentals of Entera Bio

Stock Based Compensation To Revenue

Entera Bio Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Invested Capital	Net Working Capital	Current Deferred Revenue	Net Receivables	Capital Surpluse	Long Term Debt Total	Common Stock
Total Assets		0.82	0.81	-0.96	-0.72	-0.25	-0.82	-0.64	0.72	1.0	-0.6	-0.52	0.61	0.85	0.65	-0.13	-0.67	0.65	-0.21	-0.59
Total Stockholder Equity	0.82		1.0	-0.88	-0.88	-0.51	-0.74	-0.96	0.72	0.82	-0.92	-0.72	0.69	1.0	0.4	0.02	-0.84	0.83	-0.36	-0.76
Net Tangible Assets	0.81	1.0		-0.88	-0.9	-0.53	-0.74	-0.97	0.72	0.82	-0.92	-0.75	0.67	0.99	0.4	0.0	-0.86	0.84	-0.41	-0.78
Net Debt	-0.96	-0.88	-0.88		0.83	0.26	0.78	0.74	-0.85	-0.96	0.64	0.63	-0.66	-0.91	-0.52	0.05	0.78	-0.77	0.28	0.7
Retained Earnings	-0.72	-0.88	-0.9	0.83		0.64	0.75	0.85	-0.71	-0.73	0.77	0.9	-0.55	-0.88	-0.29	0.06	0.96	-0.92	0.61	0.91
Accounts Payable	-0.25	-0.51	-0.53	0.26	0.64		0.4	0.58	-0.02	-0.26	0.69	0.63	-0.31	-0.47	-0.17	0.02	0.68	-0.65	0.43	0.74
Long Term Debt	-0.82	-0.74	-0.74	0.78	0.75	0.4		0.61	-0.66	-0.82	0.65	0.58	-0.56	-0.77	-0.2	-0.08	0.66	-0.65	0.32	0.59
Total Liab	-0.64	-0.96	-0.97	0.74	0.85	0.58	0.61		-0.63	-0.64	0.95	0.73	-0.64	-0.95	-0.24	-0.08	0.83	-0.81	0.41	0.75
Short Long Term Debt	0.72	0.72	0.72	-0.85	-0.71	-0.02	-0.66	-0.63		0.72	-0.46	-0.45	0.53	0.77	0.15	0.12	-0.61	0.7	-0.09	-0.55
Total Current Assets	1.0	0.82	0.82	-0.96	-0.73	-0.26	-0.82	-0.64	0.72		-0.6	-0.53	0.59	0.85	0.65	-0.14	-0.68	0.65	-0.21	-0.6
Short Term Debt	-0.6	-0.92	-0.92	0.64	0.77	0.69	0.65	0.95	-0.46	-0.6		0.67	-0.63	-0.89	-0.23	-0.09	0.76	-0.75	0.36	0.68
Intangible Assets	-0.52	-0.72	-0.75	0.63	0.9	0.63	0.58	0.73	-0.45	-0.53	0.67		-0.51	-0.69	-0.2	0.09	0.94	-0.84	0.86	0.81
Property Plant Equipment	0.61	0.69	0.67	-0.66	-0.55	-0.31	-0.56	-0.64	0.53	0.59	-0.63	-0.51		0.69	0.09	0.58	-0.66	0.66	-0.15	-0.55
Net Invested Capital	0.85	1.0	0.99	-0.91	-0.88	-0.47	-0.77	-0.95	0.77	0.85	-0.89	-0.69	0.69		0.39	0.03	-0.83	0.83	-0.33	-0.75
Net Working Capital	0.65	0.4	0.4	-0.52	-0.29	-0.17	-0.2	-0.24	0.15	0.65	-0.23	-0.2	0.09	0.39		-0.56	-0.29	0.21	-0.09	-0.29
Current Deferred Revenue	-0.13	0.02	0.0	0.05	0.06	0.02	-0.08	-0.08	0.12	-0.14	-0.09	0.09	0.58	0.03	-0.56		0.0	0.06	0.25	-0.12
Net Receivables	-0.67	-0.84	-0.86	0.78	0.96	0.68	0.66	0.83	-0.61	-0.68	0.76	0.94	-0.66	-0.83	-0.29	0.0		-0.96	0.64	0.89
Capital Surpluse	0.65	0.83	0.84	-0.77	-0.92	-0.65	-0.65	-0.81	0.7	0.65	-0.75	-0.84	0.66	0.83	0.21	0.06	-0.96		-0.47	-0.85
Long Term Debt Total	-0.21	-0.36	-0.41	0.28	0.61	0.43	0.32	0.41	-0.09	-0.21	0.36	0.86	-0.15	-0.33	-0.09	0.25	0.64	-0.47		0.52
Common Stock	-0.59	-0.76	-0.78	0.7	0.91	0.74	0.59	0.75	-0.55	-0.6	0.68	0.81	-0.55	-0.75	-0.29	-0.12	0.89	-0.85	0.52

Click cells to compare fundamentals

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	1.7 M	2 M
Stock Based Compensation To Revenue	15.09	15.85

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Entera Stock Based Compensation from 2010 to 2024

Latest Entera Bio's Stock Based Compensation Growth Pattern

Entera Stock Based Compensation Regression Statistics

Entera Stock Based Compensation History

Other Fundumenentals of Entera Bio

Entera Bio Stock Based Compensation component correlations

About Entera Bio Financial Statements

Also Currently Popular

Additional Tools for Entera Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY